The Food and Drug Administration has given tentative approval to Alembic's rivaroxaban tablets in dosage strengths of 10 mg, 15 mg, and 20 mg. The product is the generic of Janssen’s Xarelto tablets, ...

Aurobindo has obtained the Food and Drug Administration’s green light for rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. Rivaroxaban tablets are used to reduce the risk of ...

The European Society of Cardiology (ESC) has published new clinical practice guidelines on the management of diabetes and ‘chronic coronary syndromes (CCS)’, which replace the 2013 recommendations for ...

RARITAN, N.J., July 8, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing pediatric patients (aged ...

Johnson & Johnson and Bayer’s Xarelto, gradually losing share to Pfizer and Bristol-Myers Squibb’s Eliquis, just won a much-needed new indication analysts figure is worth $1.5 billion in the U.S.

Despite panel's endorsement, some doctors harbor concerns over the drug. Sept. 9, 2011— -- ADELPHI, Md. -- A U.S. Food and Drug Administration advisory committee has voted 9-2, with one ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, ...

Staff scientists at the Food and Drug Administration recommend that the agency reject Xarelto, a new blood thinner being developed by Bayer and Johnson & Johnson. The review, which can be found here, ...

The US Food and Drug Administration (FDA) today expanded the approved use of rivaroxaban (Xarelto, Bayer/Johnson & Johnson) to include treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE ...

Although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin. In this ...